Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-06-14

FDA Approved: LAMOTRIGINE — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approves Ascend Laboratories, LLC's original ANDA for lamotrigine, enabling the marketing of a lamotrigine generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)

Snippet

ORIG AP for LAMOTRIGINE (LAMOTRIGINE)